Abnova Corporation, headquartered in Taiwan (TW), is a leading player in the biotechnology industry, specialising in the development and production of high-quality antibodies and related products. Founded in 2004, the company has established a strong presence in major operational regions, including North America and Europe, catering to the needs of researchers and institutions worldwide. Abnova's core offerings include a comprehensive range of monoclonal and polyclonal antibodies, recombinant proteins, and assay kits, distinguished by their exceptional specificity and reliability. The company has achieved notable milestones, such as the launch of its extensive antibody catalogue, which supports various applications in life sciences research. With a commitment to innovation and quality, Abnova has positioned itself as a trusted partner in the global biotechnology market, recognised for its contributions to advancing scientific discovery.
How does Abnova (Taiwan) Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Abnova (Taiwan) Corporation's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Abnova (Taiwan) Corporation currently does not have available carbon emissions data, as indicated by the absence of specific figures for emissions in kg CO2e. Consequently, there are no reported Scope 1, Scope 2, or Scope 3 emissions totals. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. Without these commitments or data, it is unclear how Abnova plans to address its carbon footprint or contribute to climate action. As a result, Abnova's current climate strategy and emissions profile remain undefined, highlighting a potential area for future development in sustainability practices.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Abnova (Taiwan) Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.